Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immune Thrombocytopenia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00359463
What this trial is testing

Study Of Eltrombopag in Healthy Subjects and Volunteers With Mild, Moderate or Severe Hepatic Impairment

Who this might be right for
Purpura, Thrombocytopaenic, Idiopathic
GlaxoSmithKline 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05023915
What this trial is testing

Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Who this might be right for
Immune Thrombocytopenia
Shandong University 106
Not applicableStudy completedNCT05613296
What this trial is testing

Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP

Who this might be right for
ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
Gruppo Italiano Malattie EMatologiche dell'Adulto 95
Testing effectiveness (Phase 2)Study completedNCT02273960
What this trial is testing

Study to Evaluate Safety and Efficacy in Adult Subjects With ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT01568333
What this trial is testing

A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Shandong University 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07278908
What this trial is testing

Avatrombopag Combined With All-trans Retinoic Acid in the Treatment of Primary Immune Thrombocytopenia

Who this might be right for
ITP - Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China 248
Not applicableStudy completedNCT07150286
What this trial is testing

Helicobacter Pylori Eradication Therapy for Immune Thrombocytopenia (ITP) Patients in Iraq

Who this might be right for
Immune Thrombocytopenic PurpuraHELICOBACTER PYLORI INFECTIONS
Al-Mustansiriyah University 100
Testing effectiveness (Phase 2)UnknownNCT05353673
What this trial is testing

The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune ThrombocytopeniaBlood Coagulation DisordersThrombocytopenia+1 more
Peking University People's Hospital 120
Testing effectiveness (Phase 2)UnknownNCT04747080
What this trial is testing

The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Study completedNCT01143038
What this trial is testing

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Amgen 75
Large-scale testing (Phase 3)Study completedNCT04428255
What this trial is testing

A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP

Who this might be right for
Primary Immune Thrombocytopenic Purpura
Harbour BioMed (Guangzhou) Co. Ltd. 36
Not applicableLooking for participantsNCT05694325
What this trial is testing

Biologic Characterization of Patients With ITP

Who this might be right for
Immune Thrombocytopenia
Gruppo Italiano Malattie EMatologiche dell'Adulto 200
Testing effectiveness (Phase 2)UnknownNCT05281068
What this trial is testing

The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
ITPImmune Thrombocytopenia
Peking University People's Hospital 120
Testing effectiveness (Phase 2)Looking for participantsNCT06721013
What this trial is testing

Pirtobrutinib in Participants With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia (ITP)
Eli Lilly and Company 68
Not applicableUnknownNCT01970189
What this trial is testing

The International ITP Registry

Who this might be right for
Thrombocytopenia
South Eastern Sydney Local Health District 500
Testing effectiveness (Phase 2)Study completedNCT00003619
What this trial is testing

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMyelodysplastic Syndromes+1 more
Drexel University College of Medicine
Testing effectiveness (Phase 2)Ended earlyNCT00074165
What this trial is testing

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Who this might be right for
Brain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/OrganLymphoma+1 more
OHSU Knight Cancer Institute 17
Testing effectiveness (Phase 2)Looking for participantsNCT07421167
What this trial is testing

Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)Primary Evans Syndrome (ES)
Novartis Pharmaceuticals 164
Large-scale testing (Phase 3)WithdrawnNCT01734057
What this trial is testing

Recombinant Human Thrombopoietin (rhTPO) Combining Rituximab Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)

Who this might be right for
PurpuraIdiopathic Thrombocytopenic Purpura
Shandong University
Not applicableWithdrawnNCT01864512
What this trial is testing

Alteration of Different Immune Parameters in Immune Thrombocytopenia （ITP） Patients Receiving Eltrombopag Treatment

Who this might be right for
Immune Thrombocytopenia
Shandong University
Next Page